These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29222389)

  • 1. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia.
    Taylor EB; Sasser JM
    Clin Sci (Lond); 2017 Dec; 131(24):2911-2917. PubMed ID: 29222389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia.
    Kopcow HD; Karumanchi SA
    J Reprod Immunol; 2007 Dec; 76(1-2):23-9. PubMed ID: 17490755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells and pre-eclampsia.
    Sargent IL; Borzychowski AM; Redman CW
    J Reprod Immunol; 2007 Dec; 76(1-2):40-4. PubMed ID: 17482272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of invariant NKT cells in pre-eclampsia.
    Miko E; Szereday L; Barakonyi A; Jarkovich A; Varga P; Szekeres-Bartho J
    Am J Reprod Immunol; 2008 Aug; 60(2):118-26. PubMed ID: 18573130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preeclampsia is Characterized by Fetal NK Cell Activation and a Reduction in Regulatory T Cells.
    Loewendorf AI; Nguyen TA; Yesayan MN; Kahn DA
    Am J Reprod Immunol; 2015 Sep; 74(3):258-67. PubMed ID: 25962852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of immunity in the pathogenesis and development of pre-eclampsia.
    Lu HQ; Hu R
    Scand J Immunol; 2019 Nov; 90(5):e12756. PubMed ID: 30739345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T cells in Preeclampsia: An updated review.
    Hashemi V; Dolati S; Hosseini A; Gharibi T; Danaii S; Yousefi M
    Biomed Pharmacother; 2017 Nov; 95():412-418. PubMed ID: 28863381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia.
    Molvarec A; Shiozaki A; Ito M; Toldi G; Stenczer B; Szarka A; Nakashima A; Vásárhelyi B; Rigó J; Saito S
    J Reprod Immunol; 2011 Sep; 91(1-2):56-63. PubMed ID: 21763002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of NK cells in preeclampsia.
    Fukui A; Yokota M; Funamizu A; Nakamua R; Fukuhara R; Yamada K; Kimura H; Fukuyama A; Kamoi M; Tanaka K; Mizunuma H
    Am J Reprod Immunol; 2012 Apr; 67(4):278-86. PubMed ID: 22364232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia.
    Molvarec A; Blois SM; Stenczer B; Toldi G; Tirado-Gonzalez I; Ito M; Shima T; Yoneda S; Vásárhelyi B; Rigó J; Saito S
    Clin Immunol; 2011 Apr; 139(1):48-56. PubMed ID: 21292557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonates born to pre-eclamptic mothers have a higher percentage of natural killer cells (CD3-/CD56+16+) in umbilical cord blood than those without pre-eclampsia.
    Bujold E; Chaiworapongsa T; Romero R; Gervasi MT; Espinoza J; Goncalves LF; Berman S; Yoon BH; Kim YM
    J Matern Fetal Neonatal Med; 2003 Nov; 14(5):305-12. PubMed ID: 14986803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic characteristics of preeclampsia, a comprehensive review.
    Ahn H; Park J; Gilman-Sachs A; Kwak-Kim J
    Am J Reprod Immunol; 2011 Apr; 65(4):377-94. PubMed ID: 20825381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells.
    Borzychowski AM; Croy BA; Chan WL; Redman CW; Sargent IL
    Eur J Immunol; 2005 Oct; 35(10):3054-63. PubMed ID: 16134082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of NKG2C gene deletion and CCR5Δ32 in Pre-eclampsia-Approaching the effect of innate immune gene variants in pregnancy.
    Kaminski VL; Ellwanger JH; Sandrim V; Pontillo A; Chies JAB
    Int J Immunogenet; 2019 Apr; 46(2):82-87. PubMed ID: 30786156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune responses in the pathophysiology of preeclampsia.
    Miller D; Motomura K; Galaz J; Gershater M; Lee ED; Romero R; Gomez-Lopez N
    J Leukoc Biol; 2022 Jan; 111(1):237-260. PubMed ID: 33847419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers.
    Phoswa WN; Naicker T; Ramsuran V; Moodley J
    Inflamm Res; 2019 Jan; 68(1):47-57. PubMed ID: 30276649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tumor necrosis factor in triggering activation of natural killer cell, multi-organ mitochondrial dysfunction and hypertension during pregnancy.
    Jayaram A; Deer E; Amaral LM; Campbell N; Vaka VR; Cunningham M; Ibrahim T; Cornelius DC; LaMarca BB
    Pregnancy Hypertens; 2021 Jun; 24():65-72. PubMed ID: 33677421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia.
    Toldi G; Rigó J; Stenczer B; Vásárhelyi B; Molvarec A
    Am J Reprod Immunol; 2011 Sep; 66(3):223-9. PubMed ID: 21306467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity, decidual cells, and preeclampsia.
    Yeh CC; Chao KC; Huang SJ
    Reprod Sci; 2013 Apr; 20(4):339-53. PubMed ID: 22814099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocytes and preeclampsia: The potential role of T-cell subsets and related MicroRNAs in the pathogenesis of preeclampsia.
    Zolfaghari MA; Arefnezhad R; Parhizkar F; Hejazi MS; Motavalli Khiavi F; Mahmoodpoor A; Yousefi M
    Am J Reprod Immunol; 2021 Nov; 86(5):e13475. PubMed ID: 34043850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.